Mechanisms underlying macrophage action in nerve regeneration and degeneration
巨噬细胞在神经再生和变性中作用的机制
基本信息
- 批准号:9282327
- 负责人:
- 金额:$ 47.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AVIL geneAcuteAffectAmericanAnimalsAutoimmune ProcessAxonAxotomyCCL2 geneCellsChemotherapy-Oncologic ProcedureClinicalConditioned Culture MediaDiabetes MellitusDistalEnvironmentEvaluationGangliaGene ExpressionGenerationsGenesGeneticGrowthGrowth FactorHIVHereditary DiseaseIn Situ HybridizationInfiltrationInjuryInterventionKnock-outLIF geneLesionMacrophage Colony-Stimulating Factor ReceptorMeasuresMediatingMedicalMicrofluidicsModelingMolecularMusMutant Strains MiceMyelinNatural regenerationNerveNerve DegenerationNerve RegenerationNeuritesNeurogliaNeuroimmuneNeuronsPeripheralPeripheral Nervous SystemPeripheral Nervous System DiseasesPeripheral nerve injuryPhagocytesPhenotypeProcessReactionRecoverySchwann CellsSignal PathwaySiteSpinal GangliaSurgical incisionsTestingThinkingTraumaUncertaintyVirusWallerian DegenerationWorkafferent nerveaxon growthcell typechemokinechemokine receptorchemotherapyconditioningcytokinedesigneffective therapyganglion cellhereditary neuropathyimprovedin vivoin vivo regenerationinhibitor/antagonistinjuredinsightknock-downmacrophagemonocytemonocyte chemoattractant protein 1 receptorneurite growthneuroinflammationneuronal cell bodynovel strategiesperipheral nerve regenerationpermissivenessregenerativeresponsesciatic nervetranscriptome sequencing
项目摘要
Peripheral nerve injury is common and occurs due to a variety of causes including trauma, diabetes, cancer
chemotherapy, autoimmune reactions, and genetic disorders. Although peripheral neurons are capable of
regenerating, this process is generally incomplete. It is therefore crucial to determine ways in which regener-
ation can be enhanced. Macrophages are thought to promote peripheral nerve regeneration after an acute
injury due to their accumulation in the distal nerve where they phagocytize axonal debris and myelin thereby
creating an environment through which axons can grow. In addition, macrophages secrete cytokines that
trigger growth factor synthesis in non-neuronal cells in the nerve. The absence of these actions has been
assumed to be the basis for the slow regeneration that occurs in the slowly degenerating Wlds mouse. How-
ever, it has been known for 20 years. In part due to our studies. that there is a second, distinct, site of mac-
rophage accumulation after injury, namely, peripheral ganglia such as dorsal root ganglia (DRGs) where the
axotomized cell bodies reside. What has remained unknown is what function these macrophages subserve.
Recent studies from our lab represent a major advance in answering this question. Work with two mutant
mouse strains, a knockout for the chemokine receptor CCR2 and the Wlds mice led to the hypothesis that
macrophage accumulation in ganglia is required for the occurrence of the conditioning lesion (CL) response,
the response in which neurite outgrowth after a lesion is increased as a consequence of an earlier condition-
ing lesion. This application is designed to test the following overall model: macrophages brought into the
DRG by the chemokine CCL2 trigger the expression of regeneration associated genes (RAGs) via the
secretion of cytokines around axotomized cell bodies and this promotes the CL response and regen-
eration in addition to any effects macrophages have on the distal nerve. To establish beyond doubt that
CCL2-dependent macrophage accumulation and the CCL2-dependent CL response are causally related,
we will use an inhibitor of colony stimulating factor 1 receptors to deplete circulating monocytes. To deter-
mine whether macrophages act directly on neuronal cell bodies, we will use microfluidic chambers in which a
neuron’s cell body and axon can be separated. Gene expression using RNAseq will be compared after ax-
otomy in CCRs -/- and wild type animals to determine which axotomy-induced genes are dependent on mac-
rophage accumulation. Since we have shown that Wallerian degeneration is normal in CCR2 -/- mice but
monocyte infiltration into DRGs is blocked, these animals will allow us to determine whether macrophage
accumulation in DRGs is required for sensory nerve regeneration in vivo. Using these novel approaches, we
will examine the mechanisms underlying the relationship between macrophage accumulation near axoto-
mized cell bodies and axonal growth. Emphasizing ganglia, unexplored sites of neuroinflammation, repre-
sents a paradigm shift from the traditional view that focuses on macrophage effects on the distal nerve.
周围神经损伤是常见的,并且由于各种原因而发生,包括创伤、糖尿病、癌症
化疗、自身免疫反应和遗传疾病。尽管外周神经元能够
再生,这个过程通常是不完整的。因此,至关重要的是确定再生剂-
可以增强。巨噬细胞被认为可以促进周围神经在急性损伤后的再生。
损伤是由于它们在远端神经中的积累,在那里它们吞噬轴突碎片和髓磷脂,
创造一个轴突生长的环境。此外,巨噬细胞分泌细胞因子,
触发神经中非神经元细胞的生长因子合成。由于没有采取这些行动,
假设这是在缓慢退化的Wlds小鼠中发生的缓慢再生的基础。怎么--
它已经被知道了20年。部分原因是我们的研究。有第二个,不同的,MAC的网站-
损伤后的噬菌体积聚,即外周神经节,如背根神经节(DRG),其中噬菌体积聚,
轴突切断的细胞体存在。目前尚不清楚这些巨噬细胞的功能是什么。
我们实验室最近的研究代表了回答这个问题的重大进展。与两个突变体合作
小鼠品系、趋化因子受体CCR 2敲除小鼠和Wlds小鼠导致了这样的假设,
巨噬细胞在神经节中的积累是发生条件性损伤(CL)反应所必需的,
损伤后神经突生长增加的反应是早期条件的结果-
ing病变。该应用程序旨在测试以下整体模型:
趋化因子CCL 2通过激活DRG,触发再生相关基因(RAGs)的表达。
轴突切断的细胞体周围分泌细胞因子,这促进了CL反应和再生。
除了巨噬细胞对远端神经的任何影响外,毫无疑问地证明
CCL 2依赖性巨噬细胞蓄积和CCL 2依赖性CL反应存在因果关系,
我们将使用集落刺激因子1受体的抑制剂来消耗循环单核细胞。为了阻止-
为了确定巨噬细胞是否直接作用于神经元细胞体,我们将使用微流体室,
神经元的胞体和轴突可以分离。使用RNAseq的基因表达将在ax-
在CCR-/-和野生型动物中进行切开术,以确定哪些轴突切开术诱导的基因依赖于mac,
噬菌体积累由于我们已经表明,Wallerian变性在CCR 2-/-小鼠中是正常的,
单核细胞浸润到DRG被阻断,这些动物将使我们能够确定巨噬细胞是否
体内感觉神经再生需要在DRG中积累。使用这些新方法,我们
将研究轴突附近巨噬细胞积聚之间关系的潜在机制,
分化的细胞体和轴突生长。强调神经节,未探索的神经炎症部位,代表-
从传统的观点,重点是对远端神经的巨噬细胞的影响,发出了一个范式转变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD E ZIGMOND其他文献
RICHARD E ZIGMOND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD E ZIGMOND', 18)}}的其他基金
Neuroinflammation in Wallerian Degeneration and Regeneration: Neutrophils Play a Primary Role as Phagocytes
华勒变性和再生中的神经炎症:中性粒细胞作为吞噬细胞发挥主要作用
- 批准号:
10447730 - 财政年份:2020
- 资助金额:
$ 47.31万 - 项目类别:
Neuroinflammation in Wallerian Degeneration and Regeneration: Neutrophils Play a Primary Role as Phagocytes
华勒变性和再生中的神经炎症:中性粒细胞作为吞噬细胞发挥主要作用
- 批准号:
10649599 - 财政年份:2020
- 资助金额:
$ 47.31万 - 项目类别:
Neuroinflammation in Wallerian Degeneration and Regeneration: Neutrophils Play a Primary Role as Phagocytes
华勒变性和再生中的神经炎症:中性粒细胞作为吞噬细胞发挥主要作用
- 批准号:
10219366 - 财政年份:2020
- 资助金额:
$ 47.31万 - 项目类别:
Mechanisms underlying macrophage action in nerve regeneration and degeneration
巨噬细胞在神经再生和变性中作用的机制
- 批准号:
9531755 - 财政年份:2016
- 资助金额:
$ 47.31万 - 项目类别:
Mechanisms underlying macrophage action in nerve regeneration and degeneration
巨噬细胞在神经再生和变性中作用的机制
- 批准号:
9175255 - 财政年份:2016
- 资助金额:
$ 47.31万 - 项目类别:
gp130 Cytokines, Diabetic Autonomic Neuropathy, and Nerve Regeneration
gp130 细胞因子、糖尿病自主神经病变和神经再生
- 批准号:
8630390 - 财政年份:2013
- 资助金额:
$ 47.31万 - 项目类别:
gp130 Cytokines, Diabetic Autonomic Neuropathy, and Nerve Regeneration
gp130 细胞因子、糖尿病自主神经病变和神经再生
- 批准号:
8738643 - 财政年份:2013
- 资助金额:
$ 47.31万 - 项目类别:
gp130 Cytokines, Diabetic Autonomic Neuropathy, and Nerve Regeneration
gp130 细胞因子、糖尿病自主神经病变和神经再生
- 批准号:
9100695 - 财政年份:2013
- 资助金额:
$ 47.31万 - 项目类别:
gp130 Cytokines, Diabetic Autonomic Neuropathy, and Nerve Regeneration
gp130 细胞因子、糖尿病自主神经病变和神经再生
- 批准号:
8529697 - 财政年份:2012
- 资助金额:
$ 47.31万 - 项目类别:
1991 GORDON RESEARCH CONFERENCE ON NEURAL PLASTICITY
1991 年戈登神经可塑性研究会议
- 批准号:
3436177 - 财政年份:1991
- 资助金额:
$ 47.31万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 47.31万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 47.31万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 47.31万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 47.31万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 47.31万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 47.31万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 47.31万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 47.31万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 47.31万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 47.31万 - 项目类别:
Standard Grant














{{item.name}}会员




